Project Grant 90CFPA0031

This Project Grant award, totaling $431,970.00, was provided by the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394). The objective of the project is to develop a culturally adapted, dyadic self-management intervention called "SAFAD" (South Asian Family Approaches to Disease) to improve self-management and mitigate the stress, loneliness, and social isolation experienced by South Asian breast cancer survivors and their...

This federal Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $637,596 to The Research Foundation For The State University Of New York to test a video-based intervention aimed at reducing defensive avoidance of colorectal cancer information and increasing screening participation. The project will conduct a randomized controlled trial to evaluate the intervention's impact on screening intentions and uptake, with a focus on reaching...

This National Cancer Institute (NCI) federal Project Grant award, under the Cancer Research Manpower (CFDA 93.398) program, provides $171,135.00 to Weill Medical College of Cornell University to develop and test a multi-level intervention to improve access to timely, curative treatment for patients with small hepatocellular carcinoma (HCC), a type of liver cancer. The key objectives of this 5-year project are to: 1) identify barriers and facilitators to timely small HCC treatment using...

This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $697,198 to the University of California, San Diego (UCSD) to develop a targeted colorectal cancer (CRC) screening strategy for adults ages 45-49. The key objectives of this 3-year research project are to: 1) characterize the acceptability of CRC screening in this age group and identify factors influencing screening uptake, and 2) evaluate the...

This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) provides $269,942 to Baystate Medical Center, Inc. to develop and pilot test a community health worker (CHW) intervention to improve lung cancer screening (LCS) uptake among Black and Hispanic communities served by community health centers. The key objectives are to: 1) jointly "transcreate" the CHW intervention with a community advisory board, 2) conduct a pilot randomized controlled...

The National Cancer Institute (NCI) awarded a $447,686 Cooperative Agreement (CFDA 93.393 - Cancer Cause and Prevention Research) to the Alaska Native Tribal Health Consortium (ANTHC) to establish the first community-engaged cohort study investigating colorectal cancer (CRC) risk factors among Alaska Native people. The 5-year project aims to enroll 1,000 individuals prior to colonoscopy screening in Anchorage and regional tribal hospitals to collect exposome data, medical histories, and...

This federal Cooperative Agreement award of $2,514,759.00, awarded on July 8, 2024 by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research), will fund the establishment of the National ASPIRE - Asian American Prospective Research Cohort. The cohort will include 20,000 Asian American men and women ages 40-75 recruited from California, New York, New Jersey, and Pennsylvania, with the goal of examining the impact of structural and social determinants of health on cancer...

This federal Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $794,090 to the University of Oklahoma Health Sciences Center to develop and pilot test culturally sensitive digital outreach interventions to increase rates of diagnostic colonoscopy among Native American patients in Oklahoma. The key activities under this 2-year award include: 1) co-developing and integrating mobile health outreach strategies (SMS texts, videos) and...

This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), provides $192,610 to The University of Kentucky Research Foundation to evaluate the impact of social determinants of health (SDOH) on early-onset colorectal cancer (EOCRC) diagnosis, treatment delays, and survival. The study aims to elucidate the relationship between SDOH measures and CRC diagnosis, and whether these associations are modified by age,...

This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), aims to establish the feasibility of gastric cancer screening in diverse high-risk populations in the United States. The $564,414 award will support two key activities: Development and validation of a predictive model based on electronic health record (EHR) data to accurately identify individuals at high risk for gastric cancer. This will involve refining...